Cortexyme Appoints June Bray to its Board of Directors
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on rare and degenerative diseases, today announced the appointment of June Bray, a pharmaceutical industry veteran and global drug development and regulatory process expert, to the company...
June Bray David Lamond Stacy Roughan Cortexyme Inc Corporate Communications Investor Relations Hoechst Roussel Pharmaceuticals
Source: pharmiweb.com